These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21301482)

  • 1. Insights into human CD8(+) T-cell memory using the yellow fever and smallpox vaccines.
    Ahmed R; Akondy RS
    Immunol Cell Biol; 2011 Mar; 89(3):340-5. PubMed ID: 21301482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines.
    Miller JD; van der Most RG; Akondy RS; Glidewell JT; Albott S; Masopust D; Murali-Krishna K; Mahar PL; Edupuganti S; Lalor S; Germon S; Del Rio C; Mulligan MJ; Staprans SI; Altman JD; Feinberg MB; Ahmed R
    Immunity; 2008 May; 28(5):710-22. PubMed ID: 18468462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immune memory to yellow fever and smallpox vaccination.
    Wrammert J; Miller J; Akondy R; Ahmed R
    J Clin Immunol; 2009 Mar; 29(2):151-7. PubMed ID: 19052852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response.
    Akondy RS; Monson ND; Miller JD; Edupuganti S; Teuwen D; Wu H; Quyyumi F; Garg S; Altman JD; Del Rio C; Keyserling HL; Ploss A; Rice CM; Orenstein WA; Mulligan MJ; Ahmed R
    J Immunol; 2009 Dec; 183(12):7919-30. PubMed ID: 19933869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal dynamics of the primary human T cell response to yellow fever virus 17D as it matures from an effector- to a memory-type response.
    Blom K; Braun M; Ivarsson MA; Gonzalez VD; Falconer K; Moll M; Ljunggren HG; Michaëlsson J; Sandberg JK
    J Immunol; 2013 Mar; 190(5):2150-8. PubMed ID: 23338234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial viral load determines the magnitude of the human CD8 T cell response to yellow fever vaccination.
    Akondy RS; Johnson PL; Nakaya HI; Edupuganti S; Mulligan MJ; Lawson B; Miller JD; Pulendran B; Antia R; Ahmed R
    Proc Natl Acad Sci U S A; 2015 Mar; 112(10):3050-5. PubMed ID: 25713354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-lasting stem cell-like memory CD8+ T cells with a naïve-like profile upon yellow fever vaccination.
    Fuertes Marraco SA; Soneson C; Cagnon L; Gannon PO; Allard M; Abed Maillard S; Montandon N; Rufer N; Waldvogel S; Delorenzi M; Speiser DE
    Sci Transl Med; 2015 Apr; 7(282):282ra48. PubMed ID: 25855494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Origin and differentiation of human memory CD8 T cells after vaccination.
    Akondy RS; Fitch M; Edupuganti S; Yang S; Kissick HT; Li KW; Youngblood BA; Abdelsamed HA; McGuire DJ; Cohen KW; Alexe G; Nagar S; McCausland MM; Gupta S; Tata P; Haining WN; McElrath MJ; Zhang D; Hu B; Greenleaf WJ; Goronzy JJ; Mulligan MJ; Hellerstein M; Ahmed R
    Nature; 2017 Dec; 552(7685):362-367. PubMed ID: 29236685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 17D-204 Vaccine Strain-Induced Protection against Virulent Yellow Fever Virus Is Mediated by Humoral Immunity and CD4+ but not CD8+ T Cells.
    Watson AM; Lam LK; Klimstra WB; Ryman KD
    PLoS Pathog; 2016 Jul; 12(7):e1005786. PubMed ID: 27463517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of the cytotoxic T cell response to a model of acute viral infection.
    DeWitt WS; Emerson RO; Lindau P; Vignali M; Snyder TM; Desmarais C; Sanders C; Utsugi H; Warren EH; McElrath J; Makar KW; Wald A; Robins HS
    J Virol; 2015 Apr; 89(8):4517-26. PubMed ID: 25653453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 17D yellow fever vaccine elicits comparable long-term immune responses in healthy individuals and immune-compromised patients.
    Wieten RW; Goorhuis A; Jonker EFF; de Bree GJ; de Visser AW; van Genderen PJJ; Remmerswaal EBM; Ten Berge IJM; Visser LG; Grobusch MP; van Leeuwen EMM
    J Infect; 2016 Jun; 72(6):713-722. PubMed ID: 27017899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Booster dose after 10 years is recommended following 17DD-YF primary vaccination.
    Campi-Azevedo AC; Costa-Pereira C; Antonelli LR; Fonseca CT; Teixeira-Carvalho A; Villela-Rezende G; Santos RA; Batista MA; Campos FM; Pacheco-Porto L; Melo Júnior OA; Hossell DM; Coelho-dos-Reis JG; Peruhype-Magalhães V; Costa-Silva MF; de Oliveira JG; Farias RH; Noronha TG; Lemos JA; von Doellinger Vdos R; Simões M; de Souza MM; Malaquias LC; Persi HR; Pereira JM; Martins JA; Dornelas-Ribeiro M; Vinhas Ade A; Alves TR; Maia Mde L; Freire Mda S; Martins Rde M; Homma A; Romano AP; Domingues CM; Tauil PL; Vasconcelos PF; Rios M; Caldas IR; Camacho LA; Martins-Filho OA
    Hum Vaccin Immunother; 2016; 12(2):491-502. PubMed ID: 26360663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics and turnover of memory CD8 T cell responses following yellow fever vaccination.
    Zarnitsyna VI; Akondy RS; Ahmed H; McGuire DJ; Zarnitsyn VG; Moore M; Johnson PLF; Ahmed R; Li KW; Hellerstein MK; Antia R
    PLoS Comput Biol; 2021 Oct; 17(10):e1009468. PubMed ID: 34648489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8+ T cells complement antibodies in protecting against yellow fever virus.
    Bassi MR; Kongsgaard M; Steffensen MA; Fenger C; Rasmussen M; Skjødt K; Finsen B; Stryhn A; Buus S; Christensen JP; Thomsen AR
    J Immunol; 2015 Feb; 194(3):1141-53. PubMed ID: 25539816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The early cellular signatures of protective immunity induced by live viral vaccination.
    Kohler S; Bethke N; Böthe M; Sommerick S; Frentsch M; Romagnani C; Niedrig M; Thiel A
    Eur J Immunol; 2012 Sep; 42(9):2363-73. PubMed ID: 22733156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective CD8+ T cell memory without help.
    Fang M; Sigal LJ
    Oncotarget; 2015 Oct; 6(30):28529-30. PubMed ID: 26356572
    [No Abstract]   [Full Text] [Related]  

  • 17. Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus.
    Edghill-Smith Y; Golding H; Manischewitz J; King LR; Scott D; Bray M; Nalca A; Hooper JW; Whitehouse CA; Schmitz JE; Reimann KA; Franchini G
    Nat Med; 2005 Jul; 11(7):740-7. PubMed ID: 15951823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mathematical modeling provides kinetic details of the human immune response to vaccination.
    Le D; Miller JD; Ganusov VV
    Front Cell Infect Microbiol; 2014; 4():177. PubMed ID: 25621280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of CD8+ T cell responses to newly identified HLA-A*0201-restricted T cell epitopes conserved among vaccinia and variola (smallpox) viruses.
    Terajima M; Cruz J; Raines G; Kilpatrick ED; Kennedy JS; Rothman AL; Ennis FA
    J Exp Med; 2003 Apr; 197(7):927-32. PubMed ID: 12668642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-lived poxvirus immunity, robust CD4 help, and better persistence of CD4 than CD8 T cells.
    Amara RR; Nigam P; Sharma S; Liu J; Bostik V
    J Virol; 2004 Apr; 78(8):3811-6. PubMed ID: 15047796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.